Clarus and McGill University Announce Exclusive Worldwide Licensing Agreement To Develop And Commercialize Technology To Treat Rare Conditions Associated With Coenzyme-Q10 Deficiencies; Clarus To Pay $350K Upfront And Up To $10.5M In Milestones